FUSA:F:F-Fidelity UCITS SICAV - Fidelity US Quality Income UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 11.288

Change

-0.09 (-0.77)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.37 (+0.70%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.92 (+0.35%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.59 (-1.01%)

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.03 (+0.19%)

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.10 (+0.04%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+0.16 (+0.16%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+11.10 (+4.60%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.35%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.60 (+0.47%)

USD 24.77B

ETFs Containing FUSA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.29% 19% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.29% 19% F 37% F
Trailing 12 Months  
Capital Gain 4.95% 51% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.95% 49% F 51% F
Trailing 5 Years  
Capital Gain 90.71% 85% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 90.71% 85% B 58% F
Average Annual (5 Year Horizon)  
Capital Gain 15.47% 88% B+ 76% C+
Dividend Return 15.47% 86% B+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.59% 56% F 88% B+
Risk Adjusted Return 133.55% 99% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike